You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MAA868

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrial Fibrillation Trial in United States (MAA868 Cohort 1, MAA868 Cohort 2, MAA868 Cohort 3)

Completed
Has Results
  • Atrial Fibrillation
  • MAA868 Cohort 1
  • +3 more
  • Beverly Hills, California
  • +5 more
Dec 24, 2021

Atrial Fibrillation (AF) Trial in Johns Creek, Charlotte, Lenoir (Abelacimab, Placebo)

Recruiting
  • Atrial Fibrillation (AF)
  • Abelacimab
  • Placebo
  • Johns Creek, Georgia
  • +2 more
Jan 25, 2023

Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Detroit (Abelacimab, Dalteparin)

Recruiting
  • Venous Thromboembolism
  • +2 more
  • Detroit, Michigan
    Henry Ford Health System
Jul 18, 2022

Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Canada, United States (Abelacimab, Apixaban)

Recruiting
  • Venous Thromboembolism
  • +2 more
  • Lexington, Kentucky
  • +2 more
Jun 6, 2022

Atrial Fibrillation Trial (MAA868, Apixaban)

Withdrawn
  • Atrial Fibrillation
  • (no location specified)
Oct 5, 2020

Thrombotic Disorders Trial (MAA868, Enoxaparin)

Withdrawn
  • Thrombotic Disorders
  • (no location specified)
Oct 5, 2020

Atrial Fibrillation (AF), Stroke Trial in Worldwide (Abelacimab, Rivaroxaban)

Active, not recruiting
  • Atrial Fibrillation (AF)
  • Stroke
  • Huntsville, Alabama
  • +93 more
Jan 25, 2023

Corellation of Mutations, TILs and Age in Breast Cancer

Completed
  • Breast Cancer
  • Corellation of Mutations, TILs and Age in Breast Cancer
  • (no location specified)
Jul 25, 2019